Mutations in oligosaccharide biosynthesis cause Congenital Disorders of Glycosylation (CDG). This pathway requires scores of genes to insure proper glycosylation of proteins that cover the surface of every cell. Most of the 14 known types (causes) of CDG were discovered within the last 4 years. Many types of CDG await discovery.
AIM 1 proposes to define the genes, mutations, and molecular basis of new types of CDG. CDG primarily affects the N-glycosylation pathway. We have now identified a group of CDG patients with defects in multiple glycosylation pathways. Among them are two siblings with mutations in a heterogeneous 8-member complex called COG (Conserved Oligomeric Golgi). COG organizes an efficient, glycosylation-competent Golgi.
In AIM 2, we will knock down the cellular expression of each COG subunit to determine the effects on glycan biosynthesis and on the fate and functional localization of individual glycosyltransferases and nucleotide sugar transporters. This may help identify other similar COG-deficient patients and explain how COG deficiency compromises glycosylation. The common goal of these aims is to explain how these mutations cause glycosylation pathology. In the long run, we want to understand their physiological and molecular basis of new disorders and provide underpinnings for patient therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK055615-05A1
Application #
6775441
Study Section
Special Emphasis Panel (ZRG1-GTIE (90))
Program Officer
Mckeon, Catherine T
Project Start
1999-08-01
Project End
2008-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
5
Fiscal Year
2004
Total Cost
$378,180
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
020520466
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Sharma, Vandana; Smolin, Jamie; Nayak, Jonamani et al. (2018) Mannose Alters Gut Microbiome, Prevents Diet-Induced Obesity, and Improves Host Metabolism. Cell Rep 24:3087-3098
Pfeffer, Stefan; Dudek, Johanna; Schaffer, Miroslava et al. (2017) Dissecting the molecular organization of the translocon-associated protein complex. Nat Commun 8:14516
Simon, Mariella T; Ng, Bobby G; Friederich, Marisa W et al. (2017) Activation of a cryptic splice site in the mitochondrial elongation factor GFM1 causes combined OXPHOS deficiency. Mitochondrion 34:84-90
Harshman, Lyndsay A; Ng, Bobby G; Freeze, Hudson H et al. (2016) Congenital nephrotic syndrome in an infant with ALG1-congenital disorder of glycosylation. Pediatr Int 58:785-8
Freeze, Hudson H (2016) Perhaps a wee bit of sugar would help. Nat Genet 48:705-7
Chan, Barden; Clasquin, Michelle; Smolen, Gromoslaw A et al. (2016) A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2. Hum Mol Genet 25:2182-2193
Ng, Bobby G; Shiryaev, Sergey A; Rymen, Daisy et al. (2016) ALG1-CDG: Clinical and Molecular Characterization of 39 Unreported Patients. Hum Mutat 37:653-60
Ng, Bobby G; Wolfe, Lynne A; Ichikawa, Mie et al. (2015) Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors. Hum Mol Genet 24:3050-7
Sharma, Vandana; Ichikawa, Mie; Freeze, Hudson H (2014) Mannose metabolism: more than meets the eye. Biochem Biophys Res Commun 453:220-8
Ichikawa, Mie; Scott, David A; Losfeld, Marie-Estelle et al. (2014) The metabolic origins of mannose in glycoproteins. J Biol Chem 289:6751-61

Showing the most recent 10 out of 84 publications